ATL this month rolled outthe relabeled version of Interspec's Apogee RX400 general radiologyultrasound scanner, which Interspec introduced last year. Thescanner has been renamed Apogee 800 and will be marketed as amid-range offering by ATL's sales force.
ATL this month rolled outthe relabeled version of Interspec's Apogee RX400 general radiologyultrasound scanner, which Interspec introduced last year. Thescanner has been renamed Apogee 800 and will be marketed as amid-range offering by ATL's sales force.
Since the merger of the two firms in May, ATL has assumed marketingresponsibilities for all radiology scanners of the combined firms,with Interspec marketing cardiology units. As a result, Apogee800 will carry the ATL logo, according to Verl Nelson, marketingcommunications manager for ATL.
ATL made minimal changes to Apogee 800 in bringing it underits wing, Nelson said. The scanner will be positioned under ATL'sUltramark 9 HDI premium offering, at a price range of $90,000to $120,000.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.